Literature DB >> 25150846

Conflicts of Interest, Selective Inertia, and Research Malpractice in Randomized Clinical Trials: An Unholy Trinity.

Vance W Berger1.   

Abstract

Recently a great deal of attention has been paid to conflicts of interest in medical research, and the Institute of Medicine has called for more research into this important area. One research question that has not received sufficient attention concerns the mechanisms of action by which conflicts of interest can result in biased and/or flawed research. What discretion do conflicted researchers have to sway the results one way or the other? We address this issue from the perspective of selective inertia, or an unnatural selection of research methods based on which are most likely to establish the preferred conclusions, rather than on which are most valid. In many cases it is abundantly clear that a method that is not being used in practice is superior to the one that is being used in practice, at least from the perspective of validity, and that it is only inertia, as opposed to any serious suggestion that the incumbent method is superior (or even comparable), that keeps the inferior procedure in use, to the exclusion of the superior one. By focusing on these flawed research methods we can go beyond statements of potential harm from real conflicts of interest, and can more directly assess actual (not potential) harm.

Entities:  

Mesh:

Year:  2014        PMID: 25150846      PMCID: PMC4339669          DOI: 10.1007/s11948-014-9576-2

Source DB:  PubMed          Journal:  Sci Eng Ethics        ISSN: 1353-3452            Impact factor:   3.525


  27 in total

1.  Improving the information content of categorical clinical trial endpoints.

Authors:  Vance W Berger
Journal:  Control Clin Trials       Date:  2002-10

2.  On the generation and ownership of alpha in medical studies.

Authors:  Vance W Berger
Journal:  Control Clin Trials       Date:  2004-12

3.  Varying the block size does not conceal the allocation.

Authors:  Vance W Berger
Journal:  J Crit Care       Date:  2006-06       Impact factor: 3.425

4.  Misguided precedent is not a reason to use permuted blocks.

Authors:  Vance W Berger
Journal:  Headache       Date:  2006 Jul-Aug       Impact factor: 5.887

5.  Do not use blocked randomization.

Authors:  Vance W Berger
Journal:  Headache       Date:  2006-02       Impact factor: 5.887

6.  Convex hull test for ordered categorical data.

Authors:  V W Berger; T Permutt; A Ivanova
Journal:  Biometrics       Date:  1998-12       Impact factor: 2.571

7.  Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Authors:  A R Jadad; R A Moore; D Carroll; C Jenkinson; D J Reynolds; D J Gavaghan; H J McQuay
Journal:  Control Clin Trials       Date:  1996-02

8.  A method for assessing the quality of a randomized control trial.

Authors:  T C Chalmers; H Smith; B Blackburn; B Silverman; B Schroeder; D Reitman; A Ambroz
Journal:  Control Clin Trials       Date:  1981-05

Review 9.  Pennsaid therapy for osteoarthritis of the knee: a systematic review and metaanalysis of randomized controlled trials.

Authors:  Tanveer E Towheed
Journal:  J Rheumatol       Date:  2006-03       Impact factor: 4.666

10.  Why most published research findings are false.

Authors:  John P A Ioannidis
Journal:  PLoS Med       Date:  2005-08-30       Impact factor: 11.613

View more
  6 in total

1.  Aware, Yet Ignorant: Exploring the Views of Early Career Researchers About Funding and Conflicts of Interests in Science.

Authors:  Meghnaa Tallapragada; Gina M Eosco; Katherine A McComas
Journal:  Sci Eng Ethics       Date:  2016-03-15       Impact factor: 3.525

2.  Risk of selection bias in randomized trials: further insight.

Authors:  Vance W Berger
Journal:  Trials       Date:  2016-10-07       Impact factor: 2.279

3.  Self-declared stock ownership and association with positive trial outcome in randomized controlled trials with binary outcomes published in general medical journals: a cross-sectional study.

Authors:  Alberto Falk Delgado; Anna Falk Delgado
Journal:  Trials       Date:  2017-07-26       Impact factor: 2.279

4.  Why statistical inference from clinical trials is likely to generate false and irreproducible results.

Authors:  Leonid Hanin
Journal:  BMC Med Res Methodol       Date:  2017-08-22       Impact factor: 4.615

5.  Characterizing permuted block randomization as a big stick procedure.

Authors:  Vance W Berger; Isoken Odia
Journal:  Contemp Clin Trials Commun       Date:  2016-01-29

Review 6.  Methodological Aspects in Studies Based on Clinical Routine Data.

Authors:  Lieven Nils Kennes
Journal:  Adv Ther       Date:  2017-09-12       Impact factor: 3.845

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.